Ear involvement in patients with rheumatoid arthritis

Otology and Neurotology

Volumn 26, Issue 4, 2005, Pages 755-761

  Takatsu, Mitsuharu ^a   Higaki, Megumu ^a,b   Kinoshita, Hirotsugu ^a   Mizushima, Yutaka ^a   Koizuka, Izumi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Audiometry; Hearing loss; Matrix metalloproteinases; Pro inflammatory Cytokines; Rheumatoid arthritis; Tympanometry

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; CYTOKINE; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; STROMELYSIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BONE CONDUCTION; CONDUCTION DEAFNESS; CONTROLLED STUDY; EAR DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEARING IMPAIRMENT; HUMAN; INFLAMMATION; MALE; MIDDLE EAR DISEASE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RHEUMATOID ARTHRITIS; TISSUE INJURY; TYMPANOMETRY;

ACOUSTIC IMPEDANCE TESTS; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUDIOMETRY, PURE-TONE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEARING LOSS, CONDUCTIVE; HEARING LOSS, SENSORINEURAL; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22644446138     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mao.0000178138.19848.bd     Document Type: Article

References (28)

1. Ozean M, Karakus MF, Gunduz OH, et al. Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int 2002;22: 16-9.
2. Raut VV, Cullen J, Cathers G. Hearing loss in rheumatoid arthritis. J Otolaryngol 2001;30:289-94.
3. Kastanioudakis I, Skevas A, Danielidis V, et al. Inner ear involvement in rheumatoid arthritis: A prospective clinical study. J Laryngol Otol 1995;109:713-8.
4. Kakani RS, Mehra YN, Deodhar SD, et al. Audiovestibular functions in rheumatoid arthritis. J Otolaryngol 1990;19:100-2.
5. Magaro M, Zoli A, Altomonte L, et al. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol 1990;8:487-90.
6. Elwany S, El Garf A, Kamel T. Hearing and middle ear function in rheumatoid arthritis. J Rheumatol 1986;13:878-81.
7. Reiter D, Konkle DF, Myers AR, et al. Middle ear immittance in rheumatoid arthritis. Arch Otolaryngol 1980;106:114-7.
8. Colletti V, Fiorino FG, Bruni L, et al. Middle ear mechanics in subjects with rheumatoid arthritis. Audiology 1997;36:136-46.
9. Biasi D, Fiorino F, Carletto A, et al. Middle ear function in rheumatoid arthritis: A multiple frequency tympanometric study. Clin Exp Rheumatol 1996;14:243-7.
10. Rosenberg JN, Moffat DA, Ramsden RT, et al. Middle ear function in rheumatoid arthritis. Ann Rheum Dis 1978;37:522-4.
11. Moffat DA, Ramsden RT, Rosenberg JN, et al. Otoadmittance measurements in patients with rheumatoid arthritis. J Laryngol Otol 1977;91:917-27.
12. Gussen R. A typical ossicle joint lesions in rheumatoid arthritis with Sicca Syndrome (Sjögren Syndrome). Arch Otolaryngol 1977;103:284-6.
13. Frade C, Martin C. Diagnostic value of the multi-frequency tympanometry in active rheumatoid arthritis. Auris Nasus Larynx 1998;25:131-6.
14. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-10.
15. Keyszer G, Lambiri I, Nagel R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1) and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis vs other surrogate markers. J Rheumatol 1999;26:251-8.
16. Omura K, Takahashi M, Omura T, et al. Changes in the concentration of plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol 2002;21: 488-92.
17. Yoo TJ, Stuart JM, Kang AH, et al. Type II collagen autoimmunity in otosclerosis and Ménière's disease. Science 1982;217: 1153-5.
18. Arnett FC, Edworthy S, Bloch DA. The American rheumatism association 1987 revised criteria for the classification of the rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Jerger J. Clinical experience with impedance audiometry. Arch Otolaryngol 1970;92:311-24.
20. Lopez-Gonzalez MA, Lucas M, Sanchez B, et al. Autoimmune deafness is not related to hyperreactivity to type II collagen. Acta Ololaryngol 1999;119:690-4.
21. Kastanioudakis I, Ziavra N, Voulgari PU, et al. Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol 2002;116:103-7.
22. Ziavra N, Politi EN, Kastanioudakis I, et al. Hearing loss in Sjogren's syndrome patients. A comparative study. Clin Exp Rheumatol 2000;18:725-8.
23. Tumiati B, Casoli P, Parmeggiani A. Hearing loss in the Sjogren syndrome. Ann Int Med 1997;126:450-3.
24. Heyworth T, Liyanage SP. A pilot study of hearing loss in patients with rheumatoid arthritis. Scand J Rheumatol 1972;1:81-3.
25. Goodwill CJ, Lord IJ, Knill Jones RP. Hearing in rheumatoid arthritis. A clinical and audiometric survey. Ann Rheum Dis 1972; 31:170-3.
26. Lebo CP, Reddell RC. The presbycusis component in occupational hearing tests. Laryngoscope 1972;82:1399-409.
27. Evans P, Halliwell B. Free radicals and hearing. Cause, consequence, and criteria. Ann N Y Acad Sci 1999;28:419-40.
28. Sorbi D, French DL, Nuovo GJ, et al. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996;39:1747-53.